Joshua D. Schein
Chief Executive Officer at Lev Development Corp.
Joshua D. Schein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Lev Development Corp. | Chief Executive Officer | 2003-06-30 | - |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Private Equity Investor | - | - |
Career history of Joshua D. Schein
Former positions of Joshua D. Schein
| Companies | Position | Start | End |
|---|---|---|---|
| SIGA TECHNOLOGIES, INC. | President | 1995-11-30 | 2001-03-31 |
| Corporate Secretary | 1995-11-30 | 2001-03-31 | |
| Virologix Corp. | Director/Board Member | 1995-12-31 | 1998-07-31 |
| Corporate Officer/Principal | 1995-12-31 | 1998-07-31 | |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Director/Board Member | 1995-11-30 | 1998-05-31 |
| Josephthal & Co (Broker) | Corporate Officer/Principal | 1993-12-31 | 1994-12-31 |
| HEMOxymed, Inc. | Corporate Officer/Principal | - | - |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Founder | 2010-05-27 | - |
| Corporate Officer/Principal | 2003-04-30 | 2010-05-27 | |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director/Board Member | 1996-05-31 | 1998-08-31 |
| Corporate Officer/Principal | 1996-05-31 | 1998-08-31 | |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Joshua D. Schein
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Brandeis University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
Statistics
International
| United States | 13 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 3 |
| President | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Virologix Corp. | Health Technology |
| Josephthal & Co (Broker) | Finance |
| Lev Development Corp. | |
| HEMOxymed, Inc. | Health Technology |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Finance |
- Stock Market
- Insiders
- Joshua D. Schein
- Experience
